In this study, we found that IFN-I is related to CXCL9+ macrophages and CD8+ T cell immunity in NPC, and then identified that tumor-intrinsic USP5 is a key suppressor of this IFN-I–activated antitumor immunity. This evidence concerns the gene CXCL9 and nasopharyngeal carcinoma.